← Back to headlines
Vertex Pharmaceuticals Announces Health Canada Acceptance for Suzetrigine
Vertex Pharmaceuticals (VRTX) announced that Health Canada has accepted its New Drug Submission (NDS) for Suzetrigine, moving the potential treatment closer to market approval in Canada.
29 May, 06:05 — 29 May, 06:05
Sources
Showing 1 of 1 sources
